Meet Novalix at RICT 2026 in Paris, France, from July 1 to 3. This 60th Anniversary Edition of the International Conference on Medicinal Chemistry is organized by The French Medicinal Chemistry Society (Société de Chimie Thérapeutique – SCT).
The conference will focus on “Interfacing Chemical Biology and Drug Discovery” with a range of scientific topics, including 18 plenary lectures and 6 short lectures.
Two plenary lectures will be delivered by the recipients of the Novalix SCT Award for Drug Discovery Chemistry.
Scaffold Hopping to Generate New PI4KIIIβ Inhibitors
Don’t miss the poster sessions! Novalix is proud to contribute with a scientific presentation on Scaffold Hopping to Generate New PI4KIIIβ Inhibitors, made by Sophie Coupa, Senior Project Manager Chemistry. More details to come soon!
More about RICT 2026
The sessions will include a wide range of topics such as:
- Expanding the Druggable Space with Covalent and Fragment-Based Chemistry
- Proximity-Inducing Modalities – Beyond Degradation
- Bioorthogonal Chemistry, Smart Molecular Probes and Prodrugs
- RNA Chemical Biology and Epitranscriptomic Modulation
- Chemoproteomics, Target Engagement
- Artificial Intelligence and Data-Driven Chemical Biology…
Come and discuss your scientific projects with our Business Development and scientific team at our booth No.4 at RICT 2026:
Event
Visit websiteDate
From
Jul 01, 2026
to
Jul 03, 2026
Location
Paris, France
Attendees
Dr Anne de Villeroché
Director Business Development
Sophie Coupa
Senior Project Manager Chemistry
Dr Luc Van Hijfte
Distinguished Research Fellow, Senior advisor Drug Discovery at Novalix, EFMC president